
|Videos|July 16, 2021
The Potential of CAR T-Cell Therapy in Adult ALL
Author(s)Eunice Wang, MD, Bijal D. Shah, MD
Eunice Wang, MD, and Bijal Shah, MD, MS, discussed unmet needs for adult patients with relapsed/refractory ALL and reflect on the current treatment landscape.
Advertisement
This content originally appeared on our sister site,
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Slams REGENXBIO's MPS II Gene Therapy RGX-121 With CRL
2
Around the Helix: Cell and Gene Therapy Company Updates – February 11, 2026
3
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
4
Guess the Therapy Answer February 11, 2026
5














